210 related articles for article (PubMed ID: 14203689)
1. [VARIATIONS IN SERUM COPPER OXIDASE (CERULOPLASMIN) IN THE COURSE OF MALIGNANT LYMPHOGRANULOMATOSIS].
ZAMFIRESCU-GHEORGHIU M; PETRESCU M; GROZEA P; GOCIU M; SIGHETEA E; VLADESCU C; CUCU F
Stud Cercet Med Interna; 1964; 5(3):263-7. PubMed ID: 14203689
[No Abstract] [Full Text] [Related]
2. CHANGES IN SERUM ALPHA-2 GLOBULINS IN RETICULOSES.
MALPAS JS; FAIRLEY GH
J Clin Pathol; 1964 Nov; 17(6):651-4. PubMed ID: 14227435
[TBL] [Abstract][Full Text] [Related]
3. INVESTIGATIONS OF THE IMMUNOLOGICAL REACTIVITY IN HAEMOBLASTOSES. II. BLOOD COMPLEMENT VALUES IN LEUKAEMIA, MALIGNANT LYMPHOMA, AND MYELOMA.
LIBANSKY J; JEZKOVA Z
Neoplasma; 1963; 10():605-19. PubMed ID: 14103648
[No Abstract] [Full Text] [Related]
4. THE VALUE OF LEUKOCYTE ALKALINE PHOSPHATASE DETERMINATIONS IN THE MALIGNANT LYMPHOMAS.
LACHER MJ; LEY AB
Cancer; 1964 Mar; 17():402-8. PubMed ID: 14132190
[No Abstract] [Full Text] [Related]
5. [THE ARTICULAR MANIFESTATIONS OF CHRONIC BLOOD DISEASES].
GUERIN C
Rev Rhum Mal Osteoartic; 1963 Dec; 30():841-2. PubMed ID: 14116408
[No Abstract] [Full Text] [Related]
6. [Protein equilibrium during splenohematic syndromes].
GEOFFROY H; TAHIRI A
Maroc Med; 1962 May; 41():498-509. PubMed ID: 13897739
[No Abstract] [Full Text] [Related]
7. Vincristine in the treatment of lymphomas and leukemias.
BOHANNON RA; MILLER DG; DIAMOND HD
Cancer Res; 1963 May; 23():613-21. PubMed ID: 13968454
[No Abstract] [Full Text] [Related]
8. [RADIOTHERAPY OF BLOOD DISEASES].
CAPUA A
Riforma Med; 1964 May; 78():573-82. PubMed ID: 14170522
[No Abstract] [Full Text] [Related]
9. Treatment of malignancies of the reticuloendothelial system.
GHRIST TD
J Iowa State Med Soc; 1963 Feb; 53():72-82. PubMed ID: 13947558
[No Abstract] [Full Text] [Related]
10. ABNORMAL KARYOTYPE FINDINGS IN BONE MARROW AND LYMPH NODE ASPIRATES OF A PATIENT WITH MALIGNANT LYMPHOMA.
TJIO JH; MARSH JC; WHANG J; FREI F
Blood; 1963 Aug; 22():178-90. PubMed ID: 14045302
[No Abstract] [Full Text] [Related]
11. [ATTEMPT AT TREATMENT OF HODGKIN'S DISEASE AND VARIOUS HEMATOSARCOMAS WITH 1-METHYL-2-P-ALLOPHANOYL-BENZYLHYDRAZINE HYDROBROMIDE].
MATHE G; SCHNEIDER M; CATTAN A; AMIEL JL; SCHWARZENBERG L; SCHLUMBERGER JR
Rev Fr Etud Clin Biol; 1964 Nov; 9():990-2. PubMed ID: 14232681
[No Abstract] [Full Text] [Related]
12. THE LOCAL INFLAMMATORY RESPONSE IN PATIENTS WITH BLOOD DYSCRASIAS AS TESTED BY THE SKIN WINDOW TECHNIQUE.
WEBER RE; HELMAN N
Bull Sinai Hosp Detroit; 1963; 11():95-9. PubMed ID: 14064458
[No Abstract] [Full Text] [Related]
13. [TUBERCULIN ANERGY AS A CRITERION OF BIOLOGICAL DELIMITATION OF MALIGNANT RETICULOPATHIES].
POPA M; POPA G; VEIZA L
Med Interna (Bucur); 1964 Jul; 16():811-8. PubMed ID: 14182762
[No Abstract] [Full Text] [Related]
14. 5 YEARS EXPERIENCE WITH DIFFERENT N-LOST-PHOSPHAMIDESTERS IN TUMOR CHEMOTHERAPY.
GROSS R
Acta Unio Int Contra Cancrum; 1964; 20():369-72. PubMed ID: 14151932
[No Abstract] [Full Text] [Related]
15. [ERYTHROCYTE GLYCOLYTIC ACTIVITY IN VARIOUS BLOOD AND LIVER DISEASES].
PETRONIO L; SARTORI S; VALAGUSSA L; MAINIERI L
Haematologica; 1963; 48():433-48. PubMed ID: 14123797
[No Abstract] [Full Text] [Related]
16. STUDY OF IMMUNOLOGIC REACTIVITY IN HEMOBLASTOSIS. CIRCULATING ANTIBODY FORMATION AS A RESPONSE TO ANTIGENIC STIMULUS IN LEUKEMIA, MALIGNANT LYMPHOMA, MYELOMA AND MYELOFIBROSIS.
LIBANSKY J
Blood; 1965 Feb; 25():169-78. PubMed ID: 14267693
[No Abstract] [Full Text] [Related]
17. PRODUCTION OF ANTIBODIES AGAINST VIRUSES IN LEUKAEMIA AND RELATED DISEASES.
HEATH RB; FAIRLEY GH; MALPAS JS
Br J Haematol; 1964 Jul; 10():365-70. PubMed ID: 14179491
[No Abstract] [Full Text] [Related]
18. ACTIVE TUBERCULOSIS IN LEUKEMIA. MALIGNANT LYMPHOMA AND MYELOFIBROSIS.
MORROW LB; ANDERSON RE
Arch Pathol; 1965 May; 79():484-93. PubMed ID: 14289001
[No Abstract] [Full Text] [Related]
19. Hexokinase and TPN-dependent dehydrogenases of leucocytes in leukaemia and other haematological disorders.
GHIOTTO G; PERONA G; DE SANDRE G; CORTESI S
Br J Haematol; 1963 Jul; 9():345-50. PubMed ID: 13947492
[No Abstract] [Full Text] [Related]
20. [Nitrogen mustard therapy of proliferative blood diseases; methods, experiences as well as application possibilities in therapy of carcinoma].
KLIMA R; HORNISCHER R
Wien Med Wochenschr; 1953 Jan; 103(1):11-4. PubMed ID: 13049846
[No Abstract] [Full Text] [Related]
[Next] [New Search]
